What medication regimen and dosing schedule are recommended for treating opioid use disorder?

Medication Regimen for Opioid Use Disorder

For most patients with opioid use disorder, initiate treatment with buprenorphine-naloxone combination at 4-24 mg daily (buprenorphine component), titrating based on withdrawal symptoms and cravings, or use methadone 30-40 mg daily with 5-10 mg increments as needed for patients at high risk of treatment dropout. 1, 2

First-Line Medication Selection Algorithm

Choose Buprenorphine-Naloxone (4:1 ratio) for:

• Socially stable patients using prescription oral opioids 2
• Patients with work/family commitments preventing daily pharmacy visits 2
• Those requiring higher cognitive functioning or psychomotor performance 2
• Patients at high methadone toxicity risk:
  • Elderly patients
  • Heavy benzodiazepine or alcohol users
  • Lower opioid tolerance
  • Prolonged QT interval risk 2
• Patients with medical/psychiatric conditions requiring regular primary care 2

Choose Methadone for:

• Injection opioid users (higher treatment retention) 2
• Adolescents and socially unstable patients at high dropout risk 2
• Pregnant women who inject opioids 2
• Patients who fail buprenorphine-naloxone despite optimal dosing 2

Critical evidence hierarchy: Both methadone and buprenorphine-naloxone are substantially more effective than abstinence-based treatment. Methadone shows higher retention rates, while buprenorphine-naloxone has lower overdose risk 2. Extended-release monthly buprenorphine (BUP-XR) demonstrates the highest probability of treatment retention and opioid abstinence 3.

Buprenorphine-Naloxone Dosing Protocol

Standard Induction (2-day protocol):

• Day 1: Start 4 mg buprenorphine-naloxone when patient shows mild withdrawal symptoms
• Titrate to effect: Most patients stabilize on 4-24 mg daily (buprenorphine component) 1
• Target maintenance: 16-24 mg daily for most patients 1, 4
• Maximum dose: 32 mg daily 5, 4

Key Induction Principles:

• Patient must be in mild opioid withdrawal before first dose to avoid precipitated withdrawal 5
• Monitor for withdrawal symptoms, cravings, and respiratory status 5
• Keep naloxone available due to variable receptor dissociation rates 5
• After titration to 16 mg, most patients require 0-1 dose adjustments 4

Alternative Dosing Strategies:

• Divided dosing for analgesia: Split daily dose into every 6-8 hours (e.g., 32 mg daily = 8 mg every 6 hours) 5
• Less-than-daily dosing: Administer multiples of daily dose to cover increased intervals 1

Methadone Dosing Protocol

Initial Dosing:

• Start: 30-40 mg daily (prevents acute withdrawal in most patients) 5
• Titration: Increase by 5-10 mg increments if withdrawal persists 5
• Monitoring: Requires careful dosing in hepatic, renal, cardiovascular disease and with drug interactions 6

Emergency Department Initiation

ED providers should offer buprenorphine initiation to appropriate patients with direct linkage to ongoing treatment 7. This approach increases outpatient treatment linkage and decreases drug use compared to standard referral 7. Current guidelines recommend the 2-day standard-dose induction regimen 8.

Critical Pitfalls to Avoid

1. Precipitated withdrawal: Never start buprenorphine until patient shows mild withdrawal symptoms 5
2. Premature discontinuation: If switching from buprenorphine to full agonists (for acute pain), use induction protocol when restarting buprenorphine 5
3. Inadequate dosing: If withdrawal, cravings, or opioid use persist on optimal buprenorphine-naloxone, promptly switch to methadone 2
4. Withholding treatment: Never withhold medication for opioid use disorder due to medical comorbidity, pregnancy, concurrent substance use, or perioperative needs 6

Treatment Switching Protocols

Buprenorphine to Methadone (for hospitalized patients with acute pain):

• Convert to methadone 30-40 mg daily 5
• Allows titration of additional opioid analgesics without receptor competition 5
• Resume buprenorphine using induction protocol after pain resolves 5

Full Agonist to Buprenorphine:

• Discontinue full agonist and wait for mild withdrawal 5
• Follow standard induction protocol 5, 1

The most important clinical decision is choosing medication for opioid use disorder over abstinence-based treatment, as both methadone and buprenorphine reduce morbidity and mortality substantially 2, 7.